Literature DB >> 8750582

Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line.

S Y Ying1, Z Zhang.   

Abstract

Inhibins and activins are members of the transforming growth factor-beta (TGF-beta) superfamily. Since TGF beta has been shown to be a potent proliferation-inhibiting agent for the breast cancer cell line MCF-7, we determined whether this cell line (a) transcribes messenger RNAs coding inhibin/activin alpha-, beta A-, and beta B-subunits and activin receptors, and (b) produces inhibin and/or activin proteins. Messenger RNAs for alpha- and beta-subunits of inhibin/activin and activin receptor II in MCF-7 cells were detected and localized using the reverse transcription-polymerase chain reaction (RT-PCR) analysis and in situ hybridization, respectively. The identity of the RT-PCR products was confirmed by DNA sequencing of PCR products. Immunocytochemically, inhibin and activin were localized in these cells. Our findings that messenger RNAs encoding inhibin alpha-subunit, inhibin/activin beta A-subunit, and activin receptor II were expressed, and inhibin/activin proteins were produced by MCF-7 cells, imply that these gonadal growth factors may have paracrine/autocrine functions in human breast cancer. Further, these observations suggest that these growth factors may be involved in regulating the growth and differentiation of human breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8750582     DOI: 10.1007/bf01806496

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  45 in total

Review 1.  Roles for transforming growth factors-beta in the genesis, prevention, and treatment of breast cancer.

Authors:  L M Wakefield; A A Colletta; B K McCune; M B Sporn
Journal:  Cancer Treat Res       Date:  1992

2.  Purification of megakaryocyte differentiation activity from a human fibrous histiocytoma cell line: N-terminal sequence homology with activin A.

Authors:  K Fujimoto; M Kawakita; K Kato; Y Yonemura; T Masuda; H Matsuzaki; J Hirose; M Isaji; H Sasaki; T Inoue
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

3.  Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.

Authors:  N Ling; S Y Ying; N Ueno; S Shimasaki; F Esch; M Hotta; R Guillemin
Journal:  Nature       Date:  1986 Jun 19-25       Impact factor: 49.962

4.  Effects of bovine inhibin, transforming growth factor-beta and bovine Activin-A on granulosa cell differentiation.

Authors:  L A Hutchinson; J K Findlay; F L de Vos; D M Robertson
Journal:  Biochem Biophys Res Commun       Date:  1987-08-14       Impact factor: 3.575

5.  Localization of transforming growth factor-beta isotypes in lesions of the human breast.

Authors:  B K McCune; B R Mullin; K C Flanders; W J Jaffurs; L T Mullen; M B Sporn
Journal:  Hum Pathol       Date:  1992-01       Impact factor: 3.466

6.  Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.

Authors:  T Shikone; M M Matzuk; E Perlas; M J Finegold; K A Lewis; W Vale; A Bradley; A J Hsueh
Journal:  Mol Endocrinol       Date:  1994-08

7.  Activin is a nerve cell survival molecule.

Authors:  D Schubert; H Kimura; M LaCorbiere; J Vaughan; D Karr; W H Fischer
Journal:  Nature       Date:  1990-04-26       Impact factor: 49.962

8.  A transcript from a Drosophila pattern gene predicts a protein homologous to the transforming growth factor-beta family.

Authors:  R W Padgett; R D St Johnston; W M Gelbart
Journal:  Nature       Date:  1987 Jan 1-7       Impact factor: 49.962

9.  TGF-beta stimulation of endometrial and breast-cancer cell growth.

Authors:  J D Croxtall; A Jamil; M Ayub; A A Colletta; J O White
Journal:  Int J Cancer       Date:  1992-03-12       Impact factor: 7.396

10.  Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes.

Authors:  K C Flanders; N L Thompson; D S Cissel; E Van Obberghen-Schilling; C C Baker; M E Kass; L R Ellingsworth; A B Roberts; M B Sporn
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  2 in total

1.  Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes.

Authors:  Naomi Ohta; Susumu Ishiguro; Atsushi Kawabata; Deepthi Uppalapati; Marla Pyle; Deryl Troyer; Supriyo De; Yongqing Zhang; Kevin G Becker; Masaaki Tamura
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

Review 2.  Cancer Treatment and Bone Health.

Authors:  Catherine Handforth; Stella D'Oronzo; Robert Coleman; Janet Brown
Journal:  Calcif Tissue Int       Date:  2018-01-20       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.